From: Reverse-genetics studies of lncRNAs—what we have learnt and paths forward
lncRNA | Knockout strategy | In vivo phenotype | RNA-based rescue1 | Phenotype not attributed to lncRNA2 | Knockout technique3 | Reference |
---|---|---|---|---|---|---|
H19 | Replacement of a 3-kb gene region and 10 kb of 5′ flanking sequence of the lncRNA with a neomycin resistance cassette | Overgrowth in the animals inheriting the H19 mutation from their mothers compared to those inheriting it from their fathers | N | Y4 | HR | [32] |
H19 | Replacement of the entire lncRNA transcription unit with a neo cassette | Overgrowth (8%) | N | Y5 | HR | [33] |
H19 | Same as above | Overgrowth in the lncRNA knockouts reflected in general (up to 20%) increase in weight. Corresponding decrease in weight was observed in knockout animals overexpressing the lncRNA. | Y | HR | [34] | |
H19 | Same as in Ripoche et al. [33]. The E6.5 embryos were grafted into the wild-type or Igf2−/− recipient mice to induce teratocarcinomas. | Increased weight of experimental teratocarcinomas | N | HR | [35] | |
Knockout animals from Ripoche et al. [33] were bred with Apc∆14/+ mice | Increased number of adenomas compared with their Apc littermates | N | HR | |||
Maternal heterozygotes of the H19 knockout mice same as in Leighton et al. [32] were bred with CRP-Tag 60-3 male mice. | Acceleration of liver tumor development | N | HR | |||
H19 | Same as in Ripoche et al. [33] | Muscle hypertrophy and hyperplasia. A 50% reduction in the number of satellite cells | Y | HR | [36] | |
H19 | Same as in Ripoche et al. [33] | Increased tumor development after carcinogen diethylnitrosamine treatment | N | HR | [37] | |
H19 | Same as in Ripoche et al. [33]. The H19 heterozygous male knockout mice were bred with the wild-type mice to generate paternal and maternal knockouts. | Increased liver weights immediately after birth | N | HR | [38] | |
roX1/26 | Deletion of the roX2 gene, transposon insertion inactivation, or partial deletion of the roX1 gene | Male-specific reduction in viability in the animals lacking both roX1 and roX2 genes | Y | [39] | ||
Xist | Replacement of most of the lncRNA transcription unit with a neo cassette while leaving the promoter intact | Females carrying the Xist knockout on the paternal chromosome exhibited severe growth retardation and early embryonic lethality. | N | HR | [40] | |
Xist | Inversion of the exon 1 and deletion of the exon 4 | Embryonic lethality in paternal knockout mice | N | HR and Cre | [41] | |
Xist | Mice with loxP sites inserted into Xist intron 3 and 5 kb upstream of the somatic cell promoter (Xist2lox/2lox) were bred with Vav.Cre mice to conditionally delete Xist in murine hematopoietic stem cells. | Females developed a highly aggressive myeloproliferative neoplasm and myelodysplastic syndrome with 100% penetrance. | N | Cre | [42] | |
Xist | The Xistfl/fl or Xist∆/fl mice generated using the same knockout strategy as above were crossed with Sox2-Cre mice to conditionally delete Xist in the epiblast lineage. | Females exhibited retarded growth, abnormal development of some organs, and failure to survive past weaning age. | N | Cre | [43] | |
Xist | Xistlox/lox mice generated using the same knockout strategy as above were crossed with MMTV-Cre mice to generate animals with a mammary-specific knockout of Xist. | Acceleration of primary tumor growth in mammary glands and metastases in the brain | N | Cre | [44] | |
Malat1 | Gene inactivation using insertion of the lacZ gene and polyadenylation signals immediately downstream of the transcriptional start site | No apparent phenotype | N/A | HR | [25] | |
Malat1 | Same as above, but bred to MMTV-PyMT mice to generate MMTVPyMT;Malat1−/− females | Promotion of lung metastasis in the knockout animals with breast cancer, contradictory to the results of Arun et al. (2016) [47] | Y | HR | [45] | |
Malat1 | Deletion of a ~ 3-kb genomic region containing the 5′ end of the Malat1 gene and its promoter | No apparent phenotype | N/A | HR, FLP, and Cre | [46] | |
Malat1 | Same as Zhang et al. [46], but bred with MMTV-PyMT male mice | Reduction of branching morphogenesis in the MMTV-PyMT and Her2/neu-amplified tumor organoids, increase of cell adhesion, and loss of migration | N | HR | [47] | |
Malat1 | Same as Zhang et al. [46] | Increased brain infarct size, worsened neurological scores, and reduced sensorimotor functions | N | HR | [48] | |
Malat1 | Deletion of the complete 6982 bp Malat1 transcript sequence plus 251 bp upstream of the Malat1 transcription start site and 322 bp downstream of the Malat1 transcript end | No apparent phenotype | N/A | HR and Cre | [23] | |
Malat1 | Same as above | No apparent phenotype | N/A | HR and Cre | [24] | |
Malat1 | Same as in Eissmann et al. [23], but crossed with Apoe−/− mice | After a high-fat diet,the Apoe−/−Malat1−/− mice showed increased plaque size and infiltration of inflammatory CD45+ cells, as well as enhanced adhesion of myeloid cells to atherosclerotic arteries compared to the Apoe−/−Malat1+/+ mice. | N | HR and Cre | [49] | |
Hotair | Deletion of the exons 1 and 2 | Three notable anatomical phenotypes related to skeleton malformations | N | HR and Cre | [50] | |
Hotair | The same knockout strain as above, however, crossed into a different genetic background | No apparent phenotype attributable to the lncRNA, failure to reproduce the phenotypes above | N/A | HR and Cre | [26] | |
Hotair | Replacement of a 2.3-kb genomic sequence from exon 1 to the last annotated exon with a lacZ-neomycin resistance cassette | Morphological malformations in caudal vertebra | N | HR | [51] | |
Neat1 | Gene inactivation using insertion of the lacZ gene and polyadenylation signals immediately downstream of the transcriptional start site | No apparent phenotypes except for disappearance of paraspeckles | N/A | HR | [52] | |
Neat1 | Same as above | Stochastic failure to become pregnant in a subpopulation of the knockout animals | N | HR | [53] | |
Neat1 | Presumably the same as in Nakagawa et al. [52] | Aberrant mammary gland morphogenesis and lactation defects | N | [54] | ||
Neat1 | Same as in Nakagawa et al. [52] | Preneoplastic cells were sensitized to DNA-damage-induced cell death, and skin tumorigenesis was impaired. | N | HR | [55] | |
Neat1 | Same as in Nakagawa et al. [52] | Decrease of neointima formation following vascular injury | N | HR | [56] | |
Neat1 | Deletion of the entire lncRNA transcription unit | Reduction of inflammatory responses | N | Cas9 | [57] | |
Fendrr | Replacement of exon 1 with a transcriptional stop signal (3x pA) | Embryonic lethality and impairment of the heart and body wall | Y | HR | [58] | |
Firre | Deletion of the entire Firre gene body and promoter | Cell-specific hematopoietic phenotypes | Y | HR and Cre | [59] | |
lncKdm2b | Deletion of a 838-bp fragment containing the exon 2 | Impaired embryonic stem cell self-renewal and early embryonic lethality | Y | Cas9 | [60] | |
PCFL | Deletion of a 6475-bp region containing PCFL and adjacent sequences | Improved heart function and reduced cardiac fibrosis after myocardial infarction in heterozygous knockout animals | Y | Cas9 | [61] | |
Chaer | Deletion of exon 2 | Attenuated cardiac hypertrophy and blunted pathological fibrosis following trans-aortic constriction | N (in vitro rescue only) | Cas9 | [62] | |
linc1405 | Deletion of exon 2 | Impaired heart development and function | N (in vitro rescue only) | Cas9 | [63] | |
lincRNA-EPS | Replacement of the entire 4-kb genomic locus with a neomycin cassette | Enhanced inflammation and lethality following endotoxin challenge | N (in vitro rescue only) | HR | [64] | |
lncKdm2b | Same as in Ye et al. [60] | Early embryonic lethality. Impaired intestinal group 3 innate lymphoid cell (ILC3) maintenance and proliferation | N (in vitro rescue only) | Cas9 | [65] | |
Mice with loxP elements flanking the exon 2 of lncKdm2b were crossed with Vav-Cre+ mice to generate animals with a conditional deletion of lncKdm2b from the bone marrow. | Markedly decreased absolute numbers of ILC3s | N | Cas9 and Cre | |||
Mice with loxP elements flanking the exon 2 of lncKdm2b were crossed with Rorc-Cre+mice to generate mice with conditional deletion of lncKdm2b from ILC3s. | Remarkably decreased numbers of all ILC3 subpopulations | N | Cas9 and Cre | |||
ANRIL | Deletion of the 70-kb region on Chr 4 containing the mouse gene aligning to human 58-kb non-coding CAD risk interval | Showed a protective effect on diabetic mouse kidneys (lowering of urine volume and urine albumin levels in comparison with the wild-type diabetic animals) | N | HR and Cre | [66] | |
Blnc1 | Adipose tissue-specific deletion of the entire gene | Mice with fat-specific inactivation of Blnc1 showed impaired cold-induced thermogenesis and browning and exacerbation of obesity-associated brown fat whitening, adipose tissue inflammation, and fibrosis, leading to a more severe insulin resistance and hepatic steatosis. | N | Cas9 and Cre | [67] | |
Blnc1 | Whole body deletion of the entire gene | Liver X receptor agonist-induced rise in plasma triglyceride and hepatic steatosis was significantly blunted by Blnc1 deficiency. | N | Cas9 | [68] | |
Liver-specific deletion of the entire gene | Abrogation of high-fat diet-induced hepatic steatosis and insulin resistance and prevention of diet-induced nonalcoholic steatohepatitis | |||||
Bmncr | Deletion of the 4.92-kb sequence of Bmncr | Decreased bone mass and increased bone marrow adiposity | N | HR | [69] | |
βlinc1 | Replacement of the βlinc1 sequence with the puΔtk-EM7-kan cassette | Defective islet development and glucose-intolerance in the adult mice | N | HR | [70] | |
Charme | Insertion of a polyadenylation/MAZ cassette into the beginning of the exon 2 | Peculiar heart remodeling phenotype (changes in size, structure, and shape of the organ), morphological alteration of skeletal and cardiac muscles, and shortened lifespan | N | Cas9 and HR | [71] | |
CPR | Replacement of a 2968-bp fragment of CPR gene containing exons 1 and 2 with a neo cassette | Restored heart function after myocardial injury (increased cardiomyocyte proliferation, improved myocardial function, and reduced scar formation) | N | HR | [72] | |
Cyrano | Deletion of the first half of the exon 3 | No overt abnormalities | N/A | HR and Cre | [27] | |
Dino | Replacement of the bulk of Dino sequence with GFP | Dampened p53 signaling and ameliorated acute radiation syndrome | N | HR | [73] | |
Inactivation of promoter | ||||||
Evf2 | Insertion of a triple polyadenylation transcription stop site into the exon 1 | No apparent phenotype, except for reduced numbers of GABAergic interneurons in early postnatal hippocampus and dentate gyrus | N | HR | [74] | |
Fendrr | Replacement with a lacZ reporter cassette | Perinatal lethal and lung, heart, and gastrointestinal tract defects | N | HR | [75] | |
Fendrr | Replacement of a 19-kb genomic sequence from the exon 2 to the last annotated exon with a lacZ-neomycin resistance cassette | Perinatal lethal | N | HR | [51] | |
Flatr | Deletion of the promoter region and the majority of the exon 1 | No reported in vivo phenotype | N | Cas9 and HR | [76] | |
Deletion of the entirety of the exon 2 | Cas9 | |||||
Flicr | Deletion of the whole exon 2 | Flicr-deficient non-obese diabetic female mice showed a significantly reduced rate and incidence of overt diabetes. | N | Cas9 | [77] | |
Gm26878 | A 2.3-kb deletion involving the entire lncRNA-encoding gene | Neonatal lethal with low penetrance | N | Cas9 | [78] | |
Gomafu | Deletion of the entire lncRNA gene (157 kb) | Hyperactive behavior with increased sensitivity to the psychostimulant methamphetamine | N | HR and Cre | [79] | |
Gtl2/Meg3 | Replacement of the exons 1–5 (10 kb) with a neo cassette | Maternal knockout pups died within 4 weeks after birth. Paternal knockout mice showed severe growth retardation and perinatal lethality. Homozygous mutants survived and developed into fertile adults. | N | HR | [80] | |
Gtl2/Meg3 | Replacement of the first five exons and adjacent upstream promoter sequences of ~ 300 bp with a neo cassette | Perinatal death and skeletal muscle defects in the mice with the maternal deletion | N | HR | [81] | |
Gtl2/Meg3 | Same as above | Skeletal muscle defects and perinatal death in the maternal knockout animals, as well as increased microvessel formation in the brain | N | HR | [82] | |
Gtl2/Meg3 | Same as above | Increased microvessel formation in the brain | N | HR | [83] | |
Hottip | Replacement of the 4.8-kb genomic sequence from the exon 1 to the last annotated exon with a lacZ-neomycin resistance cassette | Gastrocnemius muscle defects and hindlimb skeletal malformation | N | HR | [51] | |
Linc-Brn1b | Replacement with a lacZ reporter cassette | Growth defects (reduced number of intermediate progenitor cells in the cerebral cortex, abnormal cortical lamination and disorganization of the barrel cortex, reduced body weight) | N | HR | [75] | |
Linc-pint | Replacement with a lacZ reporter cassette | Growth defects (noticeably smaller and reduced body weight) | N | HR | [75] | |
Linc-pint | Replacement of the 32-kb genomic sequence from the exon 2 to the last annotated exon with a lacZ-neomycin resistance cassette | Growth deficiency (slower growth rate, age-dependent abnormal hindlimb clasping posture, fur loss, lower fat content and femur bone mineral density, decreased muscle mass, and lordokyphosis) | N | HR | [51] | |
Linc-RAM | Deletion of the exon 2 | Delayed muscle regeneration | N | HR and Cre | [84] | |
lincRNA-p21 | Mice with loxP sites flanking the p53 response element in the promoter and exon 1 of the lncRNA were crossed with the Deletor Cre mice to achieve a conditional knockout. | No significant abnormalities | N/A | HR, FLP and Cre | [28] | |
LncDACH1 | LncDACH1Flox/Flox mice were crossed with α-myosin heavy chain Cre mice to generate mice with a cardiac myocyte-specific knockout of LncDACH1. | Increased calcium transient, cell shortening, and improved cardiac function of transverse aortic constriction induced heart failure mice. | N | Cas9 and Cre | [85] | |
lncGata6 | Deletion of the region from the exon 2 to the exon 4 | Impaired stemness of intestinal stem cells (ISCs) and intestinal regeneration | N | Cas9 | [86] | |
Insertion of an SV40 poly(A) (STOP) module into the promoter of the lncRNA | Same as above | |||||
Mutation in the lncRNA exon 4 | Same as above | |||||
Insertion of loxP sequences flanking the exons 2–4 of the lncGata6 locus and establishing Lgr5GFP-CreERT2; Rosa26lsl-lacZ; lncGata6f/f mice | Reduction of ISCs with suppressed cycling and proliferation of ISCs compared to Lgr5GFP-CreERT2; Rosa26lsl-lacZ mice | Cas9 and Cre | ||||
Lnc-mg | Conditional deletion of the exon 1 in the muscle | Muscle atrophy and the loss of muscular endurance during exercise | N | HR and Cre | [87] | |
lncOb | Deletion of the 5′ end of the lncRNA first exon | Increased fat mass with reduced plasma leptin levels and lost weight after a leptin treatment | N | Cas9 | [88] | |
lncRNA-155 | Deletion of most of the lncRNA sequence | Increased susceptibility to influenza A virus infection | N | HR | [89] | |
Mdgt | Replacement with a lacZ reporter cassette | Reduced viability and growth | N | HR | [75] | |
PEAT | Deletion of the entire lncRNA transcribed unit | No apparent phenotype | N/A | Cas9 | [29] | |
Peril | Replacement with a lacZ reporter cassette | Reduction of viability, death shortly after birth as well as reduced body weight | N | HR | [75] | |
Redrum | Deletion of the lncRNA exon 3 | No apparent phenotype | N/A | Cas9 and HR | [30] | |
Rik-201 and Rik-203 | Deletion from the beginning of second exon to the end of the third exon of the lncRNA C130071C03Rik | Abnormal brain development | N | Cas9 | [90] | |
Silc1 | Deletion of the lncRNA promoter and exon 1 | Delayed regeneration of sensory neurons following injury | N | Cas9 | [91] | |
SRA | Insertion of a lacZ/neo cassette with transcription termination signals before the exon 3 | Obesity resistance and improved glucose tolerance in knockout mice fed a high-fat diet | N | HR | [92] | |
SYISL | Deletion of a 1133-bp genomic region containing most of the SYISL transcript | Increased muscle fiber density, muscle mass, and regeneration | N | Cas9 | [93] | |
Tsix | Deletion of a 3.7-kb CpG-rich domain at the 5′ end of Tsix that included the putative promoter and transcriptional start site | The knockout mice showed normal paternal but impaired maternal transmission. Maternal inheritance is infrequent, with surviving progeny showing intrauterine growth retardation and reduced fertility. | N | HR | [94] | |
Tsix | Insertion of an IRESβgeo cassette in the second exon to disrupted lncRNA transcripts from both promoters | Inheritance of the disrupted maternal allele resulted in ectopic Xist expression and early embryonic lethality | N | HR | [95] | |
Tslrn1 | Deletion of the entire lncRNA transcribed region | Male knockout mice displayed normal fertility but a significant reduction in spermatozoa. | N | Cas9 | [96] | |
Tsx | Deletion of a 2.1-kb region encompassing the predicted promoter region, exon 1, and 160 bp of intron 1 | Male mutant animals have smaller testes and altered behavior with less fear and enhanced short-term memory. | N | HR, FLP and Cre | [97] | |
Visc-2 | Deletion of the entire lncRNA locus | No overt anatomical or behavioral phenotype | N/A | HR | [31] | |
Air/Airn | Insertion of a polyadenylation cassette to truncate Air to 4% of its length | Mice with the maternally inherited mutant allele were identical to the wild type. Animals with the paternally inherited mutant allele or homozygous mutant mice showed a 15% reduction in birth weight. | N | Y7 | HR and Cre | [98] |
Crnde | Ablation of the whole coding region | Low bone mass phenotype due to impaired osteoblast proliferation and differentiation | N (in vitro rescue only) | Possible8 | Cas9 | [99] |
Hand2as/Hand2os1/lncHand2/Uph | Deletion of the exon 1 and/or exon 2 | Liver damage and liver regeneration defects | Y | Cas9 | [100] | |
Conditional deletion of the exon 2 in hepatocytes | Severe liver injury, much poorer liver regeneration capacity, and a smaller liver mass | N | Cas9 and Cre | |||
Hand2as/Hand2os1/lncHand2/Uph | Insertion of a triple polyadenylation sequence into the exon 2 | Right ventricular hypoplasia and embryonic lethality | N | Y9 | TALENs | [101] |
Hand2as/Hand2os1/lncHand2/Uph | Deletion of the entire lncRNA locus | Septum lesion, heart hypoplasia, and perinatal death | N | Y10 | Cas9 | [21] |
Deletion of a 2.7-kb DNA sequence that spans exons 4 and 5 | Severe contraction defects in adult heart that progressively worsened with increasing age | |||||
Deletion of the 5′ promoter and first two exons | No discernable heart phenotypes in either embryos or adults |